Table 1

Number of randomized subjects in the analysis cohort

Analysis cohort and outcome audiogramDFMO plus sulindacPlaceboTotal
End-of-treatment audiogram138112250
 Discontinued treatment before 36 mos with off-treatment audiogram done201535
 36-mo audiogram done11897215
18-mo audiogram132740
 Discontinued treatment before 36 mos with 18-mo audiogram done only5611
 18-mo audiogram done; pending 36-mo audiogram82129
Analysis cohort total151139290